TCM
SLXP

Tygh Capital Management’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Tygh Capital Management’s Portfolio SLXP Stock Details SLXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-9,706
Closed -$1.52M – 145
2014
Q3 		$1.52M Buy
9,706
+5,854
+152% +$914K 0.33% 91
2014
Q2 		$475K Buy
+3,852
New +$475K 0.1% 116